Apogee Therapeutics Inc. (APGE) Company Profile & Statistics

Apogee Therapeutics Inc.
APGE
(Nasdaq - US)
Open
47.21
-0.04 (-0.09%)
in:usd•As of: Nov 18, 2024 12:26 UTC -5
Open
47.25
High
48.12
Low
46.35

About Apogee Therapeutics Inc.

CEO

Michael Henderson

Headquarters

221 crescent st.,building 17, suite 102b

waltham, ma 02453, united states

Auditor

Ernst & Young LLP

Employees

Share Holders

Website

www.apogeetherapeutics.com

Industry

biotechnology

Sector

health technology

Company Overview

Apogee Therapeutics LLC is a biotechnology company advancing novel, potentially therapies to address the needs of the millions of people living with immunological and inflammatory disorders. Apogee Therapeutics LLC is based in SAN FRANCISCO.

Apogee Therapeutics Inc. Statistics

Valuation Measures

Market Capitalization ²	2.13B
Enterprise Value	2.01B
Enterprise Value/EBITDA (ttm)	-10.56
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	2.90
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-21.81%
Return on Invested Capital (ttm)	-23.40%
Return on Assets (ttm)	-20.94%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-190.13M
Net Income Avi to Common (ttm)	-146.66M
Diluted EPS (ttm)	-2.42

Share Statistics

Beta (5Y Monthly)	2.93
52-Week Change	161.99%
S&P500 52-Week Change	29.64%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	58.51M
Dividend Yield	0.00%
Float ⁴	28.77M
% Held by Insiders	36.10%
% Held by Institutions	79.04%

Balance Sheet

Total Cash (mrq)	526.05M
Total Cash Per Share (mrq)	8.99
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	16.39%
Quick Ratio (mrq)	16.39%
Book Value Per Share (mrq)	12.91

Cash Flow

Operating Cash Flow Per Share (ytd)	-1.82
Free Cash Flow (ytd)	-104.61M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Apogee Therapeutics Inc.

Trade With A Regulated Broker